Results of subset analyses on overall survival (OS) from study CA184-043: Ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract
| Authors: | Drake, C. G.; Kwon, E. D.; Fizazi, K.; Bossi, A.; Van Den Eertwegh, A. J. M.; Logothetis, C.; Scher, H. I.; Beer, T. M.; McHenry, B.; Liu, D.; Gerritsen, W. R. |
| Abstract Title: | Results of subset analyses on overall survival (OS) from study CA184-043: Ipilimumab (Ipi) versus placebo (Pbo) in post-docetaxel metastatic castration-resistant prostate cancer (mCRPC) |
| Meeting Title: | 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2014 Jan 30-Feb 1 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-02-01 |
| Language: | English |
| ACCESSION: | WOS:000335318100006 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.4_suppl.2 |
| Notes: | Meeting Abstract: 2 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos |
